<?xml version="1.0" encoding="UTF-8"?>
<ref id="B171-biomedicines-08-00060">
 <label>171.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Voit</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kron</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schw√ºrzer-Voit</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sterry</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease</article-title>
  <source>J. Dtsch. Dermatol. Ges.</source>
  <year>2003</year>
  <volume>1</volume>
  <fpage>120</fpage>
  <lpage>125</lpage>
  <pub-id pub-id-type="doi">10.1046/j.1610-0387.2003.02014.x</pub-id>
  <pub-id pub-id-type="pmid">16285179</pub-id>
 </element-citation>
</ref>
